13,500 FU Nattokinase for Cardiovascular & Circulatory Support

High-activity nattokinase in one acid-resistant capsule—designed around measured enzyme activity, purposeful delivery, and human research.

PB Natto 13,500 FU acid-resistant capsule specification badge
PBE Nattokinase 13,500 FU acid-resistant capsule bottle

WHAT HAS HUMAN RESEARCH STUDIED?

Chen et al. 2022 nattokinase study snapshot
Nattokinase dose outcome chart — 10,800 FU vs 3,600 FU

Published Research:
Chen H, Chen J, Zhang F, et al. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants. Front Cardiovasc Med. 2022;9:964977.

View the study on PubMed

Why PBE Natto is Different

PB Natto 13,500 FU acid-resistant capsule specification badge

FAQ

Explore the Science Behind Nattokinase

RESEARCH-INFORMED. PURPOSEFULLY FORMULATED.